Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mucosal Immunol ; 6(5): 1006-15, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23321986

RESUMO

In the generation of a traditional immune response against invading pathogens, innate cells guide T cells by programming their differentiation. However, here we demonstrate that αß T cells have an essential role in priming innate immunity in the lung after Staphylococcus aureus enterotoxin A (SEA) inhalation. We found that SEA induces waves of cellular activation, cytokine production, and migration into the lung tissue and airways. However, this innate response was completely inhibited in the absence of αß T cells. Specifically, we found that interleukin (IL)-17A was required for the recruitment of neutrophils and monocytes into the lung. The cellular source of IL-17A was γδ T cells, which increased their IL-17A production following SEA but only in an αß T-cell-dependent manner. Thus, rapid T-cell activation orchestrates innate immunity and may be a new point of therapeutic intervention for acute lung injury.


Assuntos
Neutrófilos/imunologia , Linfócitos T/imunologia , Administração por Inalação , Animais , Movimento Celular , Células Cultivadas , Citocinas/metabolismo , Enterotoxinas/administração & dosagem , Imunidade Inata , Interleucina-17/metabolismo , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos C57BL , Receptores de Antígenos de Linfócitos T alfa-beta/metabolismo , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo
2.
Mucosal Immunol ; 5(1): 4-6, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22071661

RESUMO

Th17 cells are abundant in multiple chronic inflammatory and autoimmune diseases. Clinical trials with antibodies to interleukin (IL)-17A, one of the Th17-cell signature cytokines, have recently reported therapeutic benefit in multiple patient populations; however, in Crohn's disease the role of Th17 cells and IL-17A appears to be more complicated. The development of different subsets of Th17 cells and their relative pathogenic activities with a focus on the gut environment will be discussed.


Assuntos
Anticorpos/uso terapêutico , Doenças Autoimunes/imunologia , Doença de Crohn/imunologia , Trato Gastrointestinal/imunologia , Subpopulações de Linfócitos T/imunologia , Células Th17/imunologia , Animais , Doenças Autoimunes/tratamento farmacológico , Doença de Crohn/tratamento farmacológico , Humanos , Imunoterapia , Interleucina-17/imunologia , Ativação Linfocitária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...